![\"Eight-year-old](\"https:\/\/hudson.org.au\/wp-content\/uploads\/2022\/06\/Neve-presenting-cheque-ROC-News-story.jpg\")
In early May, Dr Simon Chu<\/a> took a break from the lab and put rubber on the road in the Ride4Research<\/a>, aiming to cover 900km in nine days from Canberra to Melbourne.<\/p>\n\n\n\n But with one day to go, the pandemic struck the crew and the last leg was called off.<\/p>\n\n\n\n Not to be deterred, six weeks later they were back, completing the journey in a group riding the last 50km from Whittlesea to the finish at the Melbourne Cricket Ground (MCG).<\/p>\n\n\n\n The star of the show was eight-year-old Neve, the youngest person diagnosed with ovarian cancer in Australia (aged just 11 months), who proudly led them across the finish line.<\/p>\n\n\n\n Channel 7 News was there to capture the excitement.<\/p>\n\n\n\n Dr Chu spends his working life at Hudson Institute of Medical Research, specialising in Granulosa Cell Tumour<\/a>, with much of his funding coming from the Rare Ovarian Cancer Foundation (ROC Inc<\/a>), who organised the ride.<\/p>\n\n\n\n Juvenile Granulosa Cell Cancer (JGCT) is a rare ovarian cancer that typically affects younger females, with Australia\u2019s youngest patient diagnosed at just 11 months old, and the oldest at 53 years. Ninety-four per cent of patients with JGCT are under 30 and currently there is no cure.<\/p>\n\n\n\n Research is needed to help understand the disease. The Ride4Research has raised $140,000 for researching this little-known cancer in the hope of developing an appropriate treatment, and new donations are always welcome.<\/p>\n\n\n\nRide4research finish line for patients<\/h2>\n\n\n\n